Collecting biospecimens for cancer research

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect and bank various biospecimens, including blood and tumor samples, from adults diagnosed with cancer or pre-malignant conditions. Participants will undergo medical evaluations and provide samples for research to better understand cancer biology and treatment responses. The study will enroll up to 500 subjects and will not involve any investigational therapies. The collected samples will be used for nucleic acid, protein, and immunological studies to support immunotherapy research.

Why it matters

Who can join: the full rules

* INCLUSION CRITERIA:

  1. Diagnosis of cancer, a premalignant/neoplastic condition or disease (such as an immunodeficiency) that increases the risk of being diagnosed with a cancer or premalignant/neoplastic condition
  2. Age \>=18 years of age
  3. ECOG performance status of 0-3.

  5\. Ability and willingness of subject to provide informed consent

Additional inclusion criteria pertinent only for participants undergoing apheresis

1. Hemoglobin \>= 8 mg/dL and platelet count \> 75 K/microL
2. Weight \>= 48 kg
3. Central line in place or adequate venous access

EXCLUSION CRITERIA:

1. Active concomitant medical or psychological illnesses that may increase the risk to the subject.
2. Inability to provide informed consent
3. Pregnant or breastfeeding women

Where it's running

• National Institutes of Health Clinical Center
  Bethesda, Maryland, United States Recruiting

Study contacts

• Principal investigator: Scott M Norberg, D.O. — National Cancer Institute (NCI)
• Study coordinator: Scott M Norberg, D.O.
• Email: scott.norberg@nih.gov
• Phone: (301) 275-9668

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Collecting tissue samples to study lymph cancer

  This study is collecting tissue samples from people with lymphoid cancers to learn more about the disease and help create better treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT01676805

• Using genetically modified T-cells to target cancer mutations in patients with metastatic cancer

  This study is testing a new treatment that uses specially modified immune cells from cancer patients to see if they can better target and shrink tumors in people with advanced cancer who haven't responded to regular treatments.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT03412877

• Targeted therapy for advanced cancers based on genetic profiling

  This study is testing whether targeted treatments based on the genetic makeup of advanced cancers can help patients with conditions like non-Hodgkin lymphoma and multiple myeloma feel better and have more effective options.

  Recruiting at 10 sites Phase 2 Canadian Cancer Trials Group · Edmonton, Alberta and 9 other locations · NCT03297606

• Using FDA-approved drugs to target specific tumor gene abnormalities in advanced cancer patients

  This study is testing if certain FDA-approved drugs can help advanced cancer patients with specific gene changes feel better when standard treatments haven't worked.

  Recruiting at 153 sites Phase 2 American Society of Clinical Oncology · Birmingham, Alabama and 180 other locations · NCT02693535

• Study of family connections in blood and lymph cancers

  This study looks at families with multiple members diagnosed with blood and lymph cancers to see if genetics and environmental factors play a role in their development.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT00626496

• Patient-specific MRD liquid biopsy for resected NSCLC

  This study tests a personalized MRD blood and bronchial washing test after surgery to see if it can signal recurrence earlier in people with resected NSCLC.

  Recruiting Yonsei University · Yongin-si, Gyeonggi-do and 2 other locations · NCT07921888

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.